Skip to main content
Caplight Logo









Zilia

Zilia

Private
CanadaHealthcare & Life Scienceshttps://ziliahealth.com/

Last Round

Debt

May 7, 2025

Total Funding Raised

$4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Zilia is a health technology company that develops a non-invasive medical platform to measure biomarkers in the eye for the early diagnosis and management of ocular, neurological, and systemic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

medical deviceophthalmologyretinal imagingspectrophotometryeye healthmedical AIbiomarker measurementnon-invasive diagnosticsdigital healthmedtechoxygen saturationclinical diagnosticshealthcare analyticsAI diagnosticseye care software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zilia Comparables

Compare Zilia with similar companies based on industry and business-model similarity.

Zilia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vasoptic Medical, Inc.
79%
Imagine Eyes
75%
AMETEK, Inc.
66%

Zilia Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtMay 7, 2025
SeedAug 11, 2021

Key People

Founding team and executive leadership

Dominic Sauvageau

Co Founder and CTO

Founding Team

Patrick Sauvageau

CEO and co-founder

Founding Team

Robin Villeneuve

CFO

Executive Team

Zilia Investors

Notable investors and investment history

Zilia investors
InvestorRounds
Investissement QuébecSeed
Anges QuebecSeed
Linearis VenturesDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 68% MoM, reaching 1.5K.

  • Jun 19, 2026

    Monthly visitors grew 196% MoM, reaching 865.

Zilia Filings

Explore SEC and related filing metadata, where available.

Zilia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Zilia's valuation, stock price, and market status.

Is Zilia a public or private company?

Zilia is a private company.

What is the current stock price of Zilia?

Zilia is a private company with no public stock price. Caplight tracks Zilia's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Zilia worth (valuation)?

Valuation information for Zilia is not publicly available.

Can I buy Zilia stock?

Zilia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Zilia's last funding round?

Zilia's most recent funding round was Debt on May 7, 2025.

Who are the main investors in Zilia?

Key investors in Zilia include Anges Quebec.

Will Zilia IPO soon?

No public IPO plans have been announced for Zilia.

How can I track Zilia secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Zilia's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCanada
Employee Range24
Year Founded2017
Last FundingMay 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?